Diagnostics Accelerator: Digital Biomarkers Program

About this program

The Alzheimer's Drug Discovery Foundation (ADDF) offers the Diagnostics Accelerator: Digital Biomarkers Program to fund the development of digital biomarkers for Alzheimer's disease and related dementias, focusing on technologies like wearables, mobile apps, and virtual reality. Funding is available in three stages—Exploratory (up to $250,000), Proof-of-Principle (up to $500,000), and Validation—with a total program budget of $500,000. Eligibility is open to researchers and clinicians worldwide from academic, nonprofit, and for-profit organizations, with strong encouragement for industry partnerships; for-profit entities must demonstrate a return on investment. Proposals must address key areas such as context of use, scalability, and commercialization potential, and data sharing is required unless restricted by regulatory or consent limitations.